Research aids nasal drug delivery
February 17, 2012 in Medications
RMIT University researchers have developed computer models to design more effective nasal sprays to provide alternate drug delivery to needles or pills.
The models explore deep into the human respiratory airway and focus on particle inhalation, allowing researchers to understand how particles move through the nasal cavity and where they deposit.
The models allow for powerful visualisation and reproduction of these particle flows and deposits.
Professor Jiyuan Tu, Deputy Head of Research and Innovation at RMIT's School of Aerospace, Mechanical and Manufacturing Engineering, is working on the project with the University's Health Innovations Research Institute.
The Federal Government's Australian Research Council has provided more than $1 million to support the work, which also involves collaboration with two US universities - Purdue and Clarkson - and the China National Nanoscience Centre.
Professor Tu, who is working with Dr Kiao Inthavong, a postdoctoral research fellow in his school, said the models enabled researchers to gain a better understanding of the toxicology and therapeutic effects of improved nasal spray devices.
"We are using what's called Computational Fluid Dynamics (CFD)," he said.
"We have developed sophisticated models of the real respiratory airway from medical imaging techniques (CT and MRI) that includes the oral and nasal cavity, larynx, pharynx, trachea and the upper regions of the lung airway.
"These areas of the respiratory airway are capable of determining how and where the inhaled particles and gases will move and eventually deposit on to the respiratory walls.
"This new technology will significantly assist new findings in biomedical and health research."
Professor Tu said CFD models also allowed insight into determining the health risks and outcomes of exposure to airborne particles and gases.
"These are sometimes difficult to determine using live humans or where invasive experimental techniques are involved," he said.
"For example, the models have tracked asbestos fibres as they enter the nasal cavity and eventually reach the deep lung regions causing lung complications such as mesothelioma."
Professor Tu said the new technology also provided powerful visualisation tools such as vector and contour plots, useful for conveying information such as the air/particle flow dynamics and its behaviour to non-health practitioners.
"For example, doctors can explain the effects of surgical procedures to the patient and family members, or engineers can develop optimised designs of room ventilation," he said.
"These studies of particle inhalation in human respiratory airways are also important for air quality - especially pollution, including dust and smoke - occupational health, dealing with bio-terrorist attacks and infectious disease outbreaks."
RMIT research projects in the emerging field have also involved industry, including the Hastie Group, D&E Air Conditioning, Airlinx and Woodwork Innovation.
Provided by RMIT University
-
Virtual surgery shows promise in personalized treatment of nasal obstruction
Apr 18, 2011 |
not rated yet |
0
-
Michigan State research sheds new light on health dangers of nanoparticles
Feb 17, 2006 |
not rated yet |
0
-
Nanotubes pose health risk, study shows
Jun 14, 2011 |
not rated yet |
0
-
Rodent study finds artificial butter chemical harmful to lungs
Mar 13, 2008 |
not rated yet |
0
-
3-D computer simulation to aid treatment of collapsed lungs
Jul 26, 2006 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Why is zone 1 in liver more prone to ischemic injury?
May 23, 2013
-
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013
-
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
- More from Physics Forums - Medical Sciences
More news stories
Merck ends development of Parkinson's disease drug
(AP)—Merck & Co. says it is ending development of an experimental Parkinson's disease drug because the drug wasn't working.
Medications
22 hours ago |
1 / 5 (1) |
0
J&J expects 10-plus new drug applications by 2017
(AP)—Johnson & Johnson is developing what could eventually be game-changing treatments for depression and pain, and it's aiming to apply for approval of more than 10 new medicines by 2017, executives said Thursday during ...
Medications
23 hours ago |
5 / 5 (1) |
0
Experts favor US approval of Merck sleeping pill (Update)
An independent panel of experts on Wednesday recommended US approval of a new Merck sleeping pill called suvorexant, but expressed concerns over the highest dosage and risks of drowsy daytime driving.
Medications
May 22, 2013 |
not rated yet |
0
Glaxo, US partnering to develop new antibiotics
GlaxoSmithKline PLC says it's starting an unusual collaboration with the U.S. government to develop several antibiotics for both bioterrorism threats and bacterial infections resistant to current medicines.
Medications
May 22, 2013 |
not rated yet |
0
Study finds new pneumococcal vaccine appears to be as safe as previously used vaccine
The new 13-valent pneumococcal conjugate vaccine (PCV13) appears to be as safe as the previous version used prior to 2010, the 7-valent pneumococcal conjugate vaccine (PCV7), according to a Kaiser Permanente study published ...
Medications
May 22, 2013 |
not rated yet |
0
Engineered cytomegalovirus protects monkeys from HIV equivalent
(Medical Xpress)—A new study by researchers in the US has shown that an ancient virus can be modified to help in the fight against the simian immunodeficiency virus SIV, which is the equivalent in monkeys ...
Researchers identify first drug targets in childhood genetic tumor disorder
Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...
Driving and hands-free talking lead to spike in errors, study shows
Talking on a hands-free device while behind the wheel can lead to a sharp increase in errors that could imperil other drivers on the road, according to new research from the University of Alberta.
Hormone levels may provide key to understanding psychological disorders in women
Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.
Going live: Immune cell activation in multiple sclerosis
Biological processes are generally based on events at the molecular and cellular level. To understand what happens in the course of infections, diseases or normal bodily functions, scientists would need to ...
Controlling mood through the motions of mitochondria
(Medical Xpress)—Regulating the distribution of power in neurons is done by a system that makes the national electric grid look simple by comparison. Each neuron has several thousand mitochondria confined ...